Allegheny Financial Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Allegheny Financial Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,316	Closed	-$2.12M	–	215
2023 Q3	$2.12M	Buy	18,316 +1,237	+7%	+$133K	0.79%	21
2023 Q2	$1.76M	Sell	17,079 -1,237	-7%	-$131K	0.83%	23
2023 Q1	$2M	Hold	18,316	–	–	0.81%	26
2022 Q4	$2.08M	Hold	18,316	–	–	0.87%	26
2022 Q3	$1.13M	Hold	18,316	–	–	0.53%	33
2022 Q2	$1.46M	Sell	18,316 -870	-5%	-$82.4K	0.68%	30
2022 Q1	$2.02M	Sell	19,186 -1,500	-7%	-$146K	0.85%	27
2021 Q4	$2.23M	Hold	20,686	–	–	0.89%	24
2021 Q3	$2.27M	Hold	20,686	–	–	1.04%	21
2021 Q2	$1.94M	Hold	20,686	–	–	0.88%	23
2021 Q1	$1.9M	Hold	20,686	–	–	1.39%	16
2020 Q4	$1.51M	Buy	+20,686	New	+$1.54M	0.81%	26

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Allegheny Financial Group's HZNP Position: Q4 2023 in Review

Allegheny Financial Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 18,316 shares — an estimated $2.12M sold.

Allegheny Financial Group first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $2.27M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Allegheny Financial Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Allegheny Financial Group sold 18,316 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.12M.
Allegheny Financial Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
Allegheny Financial Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.27M in Q3 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Allegheny Financial Group's 13F filing for Q4 2023, filed 8 Feb 2024.